Cargando…
Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
BACKGROUND: Haemophilus influenzae is found in the nasopharynx of 80% of the human population. While colonisation with non-typeable Haemophilus influenzae (NTHi) is usually asymptomatic, it is capable of causing acute and chronic otitis media (OM) in infants, invasive disease in susceptible groups a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206646/ https://www.ncbi.nlm.nih.gov/pubmed/30373523 http://dx.doi.org/10.1186/s12866-018-1314-5 |
_version_ | 1783366389378056192 |
---|---|
author | Thomas, Stephen R. Leung, Stephanie Knox, Katy Wilkinson, Tom M. A. Staples, Karl J. Lestrate, Pascal Wauters, Dominique Gorringe, Andrew Taylor, Stephen C. |
author_facet | Thomas, Stephen R. Leung, Stephanie Knox, Katy Wilkinson, Tom M. A. Staples, Karl J. Lestrate, Pascal Wauters, Dominique Gorringe, Andrew Taylor, Stephen C. |
author_sort | Thomas, Stephen R. |
collection | PubMed |
description | BACKGROUND: Haemophilus influenzae is found in the nasopharynx of 80% of the human population. While colonisation with non-typeable Haemophilus influenzae (NTHi) is usually asymptomatic, it is capable of causing acute and chronic otitis media (OM) in infants, invasive disease in susceptible groups and is the leading cause of exacerbations of patients with chronic obstructive pulmonary disease (COPD). Current methods for assessing functional antibody immunity to NTHi are limited and labour intensive. Flow cytometric assays could provide an attractive alternative to evaluate immune responses to candidate vaccines in clinical trials. RESULTS: We have developed a duplexed flow-cytometric uptake and oxidative burst opsonophagocytosis assay (fOPA). We have also developed a duplexed antibody-mediated complement C3b/iC3b and C5b-9 deposition assay (CDA). Antibody-mediated C3b/iC3b deposition correlated with opsonophagocytic uptake (r = 0.65) and with opsonophagocytic oxidative burst (r = 0.69). Both fOPA and CDA were reproducible, with the majority of samples giving a coefficient of variation (CV) of < 20% and overall assay CVs of 14% and 16% respectively. CONCLUSIONS: The high-throughput flow cytometric assays developed here were successfully optimised for use with NTHi. Assays proved to be sensitive and highly reproducible for the measurement of bacterial uptake and oxidative burst opsonophagocytosis and antibody-mediated deposition of C3b/iC3b and C5b-9. These assays are useful tools for use in large scale epidemiological studies and to assist in the assessment of functional antibody induced by NTHi candidate vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-018-1314-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6206646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62066462018-10-31 Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae Thomas, Stephen R. Leung, Stephanie Knox, Katy Wilkinson, Tom M. A. Staples, Karl J. Lestrate, Pascal Wauters, Dominique Gorringe, Andrew Taylor, Stephen C. BMC Microbiol Methodology Article BACKGROUND: Haemophilus influenzae is found in the nasopharynx of 80% of the human population. While colonisation with non-typeable Haemophilus influenzae (NTHi) is usually asymptomatic, it is capable of causing acute and chronic otitis media (OM) in infants, invasive disease in susceptible groups and is the leading cause of exacerbations of patients with chronic obstructive pulmonary disease (COPD). Current methods for assessing functional antibody immunity to NTHi are limited and labour intensive. Flow cytometric assays could provide an attractive alternative to evaluate immune responses to candidate vaccines in clinical trials. RESULTS: We have developed a duplexed flow-cytometric uptake and oxidative burst opsonophagocytosis assay (fOPA). We have also developed a duplexed antibody-mediated complement C3b/iC3b and C5b-9 deposition assay (CDA). Antibody-mediated C3b/iC3b deposition correlated with opsonophagocytic uptake (r = 0.65) and with opsonophagocytic oxidative burst (r = 0.69). Both fOPA and CDA were reproducible, with the majority of samples giving a coefficient of variation (CV) of < 20% and overall assay CVs of 14% and 16% respectively. CONCLUSIONS: The high-throughput flow cytometric assays developed here were successfully optimised for use with NTHi. Assays proved to be sensitive and highly reproducible for the measurement of bacterial uptake and oxidative burst opsonophagocytosis and antibody-mediated deposition of C3b/iC3b and C5b-9. These assays are useful tools for use in large scale epidemiological studies and to assist in the assessment of functional antibody induced by NTHi candidate vaccines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12866-018-1314-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-29 /pmc/articles/PMC6206646/ /pubmed/30373523 http://dx.doi.org/10.1186/s12866-018-1314-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Methodology Article Thomas, Stephen R. Leung, Stephanie Knox, Katy Wilkinson, Tom M. A. Staples, Karl J. Lestrate, Pascal Wauters, Dominique Gorringe, Andrew Taylor, Stephen C. Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae |
title | Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae |
title_full | Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae |
title_fullStr | Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae |
title_full_unstemmed | Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae |
title_short | Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae |
title_sort | development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable haemophilus influenzae |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206646/ https://www.ncbi.nlm.nih.gov/pubmed/30373523 http://dx.doi.org/10.1186/s12866-018-1314-5 |
work_keys_str_mv | AT thomasstephenr developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT leungstephanie developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT knoxkaty developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT wilkinsontomma developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT stapleskarlj developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT lestratepascal developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT wautersdominique developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT gorringeandrew developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae AT taylorstephenc developmentofflowcytometricopsonophagocytosisandantibodymediatedcomplementdepositionassaysfornontypeablehaemophilusinfluenzae |